A LinkedIn post from Gameto highlights continued expansion of the Phase III clinical trial for Fertilo in the U.S., with Columbia University Fertility Center in New York joining as the latest site. The post notes that the center, led by Dr. Eric Forman, was ranked the top fertility clinic in the U.S. in Newsweek’s 2025 America’s Best Fertility Clinics and is currently the only New York location in the study.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to the post, this development appears to increase geographic access to Fertilo for eligible New York patients, who may be able to participate with covered cycles. For investors, the growing trial footprint at a highly ranked academic center could signal operational momentum, support for eventual regulatory evidence generation, and potential strengthening of Gameto’s positioning in the IVF and women’s health markets if trial outcomes are favorable.
The LinkedIn update also indicates that additional trial sites across the country are already participating and that more locations and updates are expected. This suggested expansion of the clinical network may help accelerate patient enrollment, diversify data across populations, and enhance the program’s visibility among key opinion leaders, factors that could influence the company’s longer-term commercialization prospects and partnership opportunities.